-
1.Synthesis of the breast tumor-associated antigen defined by monoclonalantibody MBRL and uses thereof 失效
标题翻译: 由单克隆抗体MBRL定义的乳腺肿瘤相关抗原的合成及其用途公开(公告)号:US5708163A
公开(公告)日:1998-01-13
申请号:US430355
申请日:1995-04-28
申请人: Samuel J. Danishefsky , Mark T. Bilodeau , Shuang Hua Hu , Tae Kyo Park , John T. Randolph , In Jong Kim , Philip O. Livingston
发明人: Samuel J. Danishefsky , Mark T. Bilodeau , Shuang Hua Hu , Tae Kyo Park , John T. Randolph , In Jong Kim , Philip O. Livingston
IPC分类号: C07H11/00 , A61K31/70 , A61K31/7028 , A61K31/7042 , A61K31/7048 , A61K38/00 , A61K39/00 , A61K39/39 , A61P35/00 , A61P37/04 , C07H3/06 , C07H15/10 , C07H15/18 , C07H17/02 , C07H17/04 , C07K1/04 , C07K9/00 , C07K16/30 , C07K16/44 , C07H1/00 , C07H5/06 , C07H17/00 , C08B37/00
CPC分类号: C07H15/10 , A61K39/0011 , C07H15/18 , C07H17/02 , C07H3/06 , C07K1/04 , C07K16/3015 , C07K16/44 , C07K9/005 , A61K38/00
摘要: The present invention provides a process for synthesizing a compound having the structure: ##STR1## wherein R is H, as well as related oligosaccharides useful as a vaccine for inducing antibodies to human breast cancer cells in an adjuvant therapy therefor.
摘要翻译: 本发明提供了一种合成具有以下结构的化合物的方法:其中R是H,以及可用作用于在其辅助治疗中诱导人乳腺癌细胞的抗体的疫苗的相关寡糖。
-
2.Synthesis of the breast tumor-associated antigen defined by monoclonal antibody MBr1 and uses thereof 失效
标题翻译: 由单克隆抗体MBr1定义的乳腺肿瘤相关抗原的合成及其用途公开(公告)号:US6090789A
公开(公告)日:2000-07-18
申请号:US977215
申请日:1997-11-24
申请人: Samuel J. Danishefsky , Mark T. Bilodeau , Shuang Hua Hu , Tae Kyo Park , John T. Randolph , In Jong Kim , Philip O. Livingston
发明人: Samuel J. Danishefsky , Mark T. Bilodeau , Shuang Hua Hu , Tae Kyo Park , John T. Randolph , In Jong Kim , Philip O. Livingston
IPC分类号: C07H11/00 , A61K31/70 , A61K31/7028 , A61K31/7042 , A61K31/7048 , A61K38/00 , A61K39/00 , A61K39/39 , A61P35/00 , A61P37/04 , C07H3/06 , C07H15/10 , C07H15/18 , C07H17/02 , C07H17/04 , C07K1/04 , C07K9/00 , C07K16/30 , C07K16/44 , C07H5/06 , C07H15/04 , G01N33/00
CPC分类号: C07H15/10 , A61K39/0011 , C07H15/18 , C07H17/02 , C07H3/06 , C07K1/04 , C07K16/3015 , C07K16/44 , C07K9/005 , A61K38/00
摘要: The present invention provides a process for synthesizing a compound having the structure: ##STR1## wherein R is H, as well as related oligosaccharides useful as a vaccine for inducing antibodies to human breast cancer cells in an adjuvant therapy therefor.
摘要翻译: 本发明提供一种合成具有以下结构的化合物的方法:其中R为H,以及可用作用于在其辅助治疗中诱导人乳腺癌细胞抗体的疫苗的相关寡糖。
-
公开(公告)号:US5543505A
公开(公告)日:1996-08-06
申请号:US213053
申请日:1993-03-15
IPC分类号: A61K38/00 , C07H3/06 , C07H17/04 , C07K9/00 , C07K14/765 , C07H15/00 , C07H15/06 , C07H17/00 , C07K1/00
CPC分类号: C07K14/765 , C07H17/04 , C07H3/06 , C07K9/00 , A61K38/00
摘要: The present invention provides a compound having the structure: ##STR1## wherein A is selected from the group consisting of (i) an amino acid bearing an .omega.-amino group or an .omega.--(C.dbd.O)-- group, (ii) an amino acid residue of a peptide, which residue bears an .omega.-amino group or an .omega.-(C.dbd.O)-- group, and (iii) an amino acid residue of a protein, which residue bears an .omega.-amino group or an .omega.-(C.dbd.O)-- group; wherein R.sub.1 is H, OH, NH.sub.2 or NHR.sub.4, where R.sub.4 is SO.sub.2 Ph, a linear or branched chain alkyl or acyl group, or an aryl group; wherein M is a saccharide wherein n is an integer from 0 to 18, and where n is greater than 1, each M is independently the same or different; wherein p is either 0 or 1; wherein R.sub.2, R.sub.3, R.sub.5 and R.sub.6 are independently the same or different and are H or OH, with the proviso that R.sub.2 and R.sub.3 are not both OH, and R.sub.5 and R.sub.6 are not both OH; wherein X and Y are independently the same or different and are H.sub.2 or O; and wherein k is an integer greater than or equal to 1, with the proviso that when A is an amino acid bearing an .omega.-amino group or an .omega.-(C.dbd.O)-- group, k is equal to 1.
摘要翻译: 本发明提供具有以下结构的化合物:其中A选自(i)具有ω-氨基或ω-(C = O) - 基团的氨基酸 ,(ii)肽的氨基酸残基,该残基具有ω-氨基或ω-(C = O) - 基团,和(iii)蛋白质的氨基酸残基,该残基具有ω- 氨基或ω-(C = O) - 基团; 其中R 1是H,OH,NH 2或NHR 4,其中R 4是SO 2 Ph,直链或支链烷基或酰基或芳基; 其中M是糖,其中n是0至18的整数,并且其中n大于1,每个M独立地相同或不同; 其中p是0或1; 其中R2,R3,R5和R6独立地相同或不同,为H或OH,条件是R2和R3不同时为OH,R5和R6不同时为OH; 其中X和Y独立地相同或不同,为H 2或O; 并且其中k是大于或等于1的整数,条件是当A是具有ω-氨基或ω-(C = O) - 基团的氨基酸时,k等于1。
-
公开(公告)号:US08937150B2
公开(公告)日:2015-01-20
申请号:US13100827
申请日:2011-05-04
申请人: David A. DeGoey , Warren M. Kati , Charles W. Hutchins , Pamela L. Donner , Allan C. Krueger , John T. Randolph , Christopher E. Motter , Lissa T. Nelson , Sachin V. Patel , Mark A. Matulenko , Ryan G. Keddy , Tammie K. Jinkerson , Yi Gao , Dachun Liu , John K. Pratt , Todd W. Rockway , Clarence J. Maring , Douglas K. Hutchinson , Charles A. Flentge , Rolf Wagner , Michael D. Tufano , David A. Betebenner , Kathy Sarris , Kevin R. Woller , Seble H. Wagaw , Jean C. Califano , Wenke Li , Daniel D. Caspi , Mary E. Bellizzi , William A. Carroll
发明人: David A. DeGoey , Warren M. Kati , Charles W. Hutchins , Pamela L. Donner , Allan C. Krueger , John T. Randolph , Christopher E. Motter , Lissa T. Nelson , Sachin V. Patel , Mark A. Matulenko , Ryan G. Keddy , Tammie K. Jinkerson , Yi Gao , Dachun Liu , John K. Pratt , Todd W. Rockway , Clarence J. Maring , Douglas K. Hutchinson , Charles A. Flentge , Rolf Wagner , Michael D. Tufano , David A. Betebenner , Kathy Sarris , Kevin R. Woller , Seble H. Wagaw , Jean C. Califano , Wenke Li , Daniel D. Caspi , Mary E. Bellizzi , William A. Carroll
IPC分类号: A61K31/66 , C07K16/00 , C07D401/14 , C07D491/113 , C07D413/14 , C07D403/14 , C07D417/14 , C07D405/14 , C07D453/00
CPC分类号: A61K31/454 , A61K31/4178 , A61K31/4184 , A61K31/422 , A61K31/435 , A61K31/4355 , A61K31/438 , A61K31/4418 , A61K31/4439 , A61K31/4545 , A61K31/496 , A61K31/506 , A61K31/5377 , A61K31/695 , A61K45/06 , C07D401/14 , C07D403/14 , C07D405/14 , C07D413/14 , C07D417/14 , C07D453/00 , C07D491/113 , C07F7/02 , Y02P20/582
摘要: Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
-
公开(公告)号:US20130023463A1
公开(公告)日:2013-01-24
申请号:US13451370
申请日:2012-04-19
申请人: Charles A. Flentge , Hui-Ju Chen , David A. DeGoey , William J. Flosi , David J. Grampovnik , Peggy P. Huang , Dale J. Kempf , Larry L. Klein , Allan C. Krueger , Darold L. Madigan , John T. Randolph , Minghua Sun , Ming C. Yeung , Chen Zhao
发明人: Charles A. Flentge , Hui-Ju Chen , David A. DeGoey , William J. Flosi , David J. Grampovnik , Peggy P. Huang , Dale J. Kempf , Larry L. Klein , Allan C. Krueger , Darold L. Madigan , John T. Randolph , Minghua Sun , Ming C. Yeung , Chen Zhao
IPC分类号: A61K31/18 , C07D213/53 , A61K31/4402 , C07D307/14 , A61K31/341 , A61K31/4418 , C07D307/52 , C07D277/30 , A61K31/426 , C07C275/24 , A61K31/197 , C07D213/86 , C07D493/04 , A61K31/34 , C07D333/20 , A61K31/381 , C07C275/16 , A61P31/18 , A61K31/513 , A61K31/496 , A61K31/7072 , A61K31/708 , A61K38/16 , C12N9/99 , C07C311/37
CPC分类号: C07D417/12 , C07C311/18 , C07C311/29 , C07C311/41 , C07C311/47 , C07C317/18 , C07D209/14 , C07D213/30 , C07D213/40 , C07D233/36 , C07D233/64 , C07D233/72 , C07D277/24 , C07D277/28 , C07D307/14 , C07D307/20 , C07D307/52 , C07D333/20 , C07D401/06 , C07D403/06 , C07D405/06 , C07D405/10 , C07D409/06 , C07D409/10 , C07D417/06 , C07D417/10 , C07D471/04 , C07D493/04
摘要: A compound of the formula is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.
摘要翻译: 公开了式的化合物作为HIV蛋白酶抑制剂。 还公开了用于抑制HIV感染的方法和组合物。
-
公开(公告)号:US20120309762A1
公开(公告)日:2012-12-06
申请号:US13587516
申请日:2012-08-16
申请人: Larry L. Klein , Hui-Ju Chen , Ming C. Yeung , Charles A. Flentge , John T. Randolph , Peggy P. Huang , Douglas K. Hutchinson , Dale J. Kempf
发明人: Larry L. Klein , Hui-Ju Chen , Ming C. Yeung , Charles A. Flentge , John T. Randolph , Peggy P. Huang , Douglas K. Hutchinson , Dale J. Kempf
IPC分类号: C07D277/24 , C07D417/12 , A61K31/4439 , A61K31/426 , A61K31/427 , A61P31/12 , C07D417/14 , A61K31/5355 , A61K31/496 , A61K31/5377 , A61K31/454 , C12N9/99 , A61K31/513
CPC分类号: A61K31/5377 , A61K31/4164 , A61K31/4178 , A61K31/4439 , A61K31/4525 , A61K31/496 , A61K31/506 , A61K45/06 , C07D213/79 , C07D277/24 , C07D277/30 , C07D277/593 , C07D417/12
摘要: The present invention features compounds of formula I or pharmaceutically acceptable salts, solvates or prodrugs thereof, and methods of using the same to inhibit the metabolizing activities of CYP enzymes. The present invention also features methods of using these compounds, salts, solvates or prodrugs to improve the pharmacokinetics of drugs that are metabolized by CYP enzymes.
-
公开(公告)号:US20120220562A1
公开(公告)日:2012-08-30
申请号:US13404429
申请日:2012-02-24
申请人: David A DeGoey , Warren M. Kati , Charles W. Hutchins , Pamela L. Donner , Allan C. Krueger , John T. Randolph , Sachin V. Patel , Mark A. Matulenko , Ryan G. Keddy , Tammie K. Jinkerson , Yi Gao , Dachun Liu , John K. Pratt , Todd W. Rockway , Clarence J. Maring , Douglas K. Hutchinson , Charles A. Flentge , Rolf Wagner , David A. Betebenner , Kathy Sarris , Kevin R. Woller , William A. Carroll
发明人: David A DeGoey , Warren M. Kati , Charles W. Hutchins , Pamela L. Donner , Allan C. Krueger , John T. Randolph , Sachin V. Patel , Mark A. Matulenko , Ryan G. Keddy , Tammie K. Jinkerson , Yi Gao , Dachun Liu , John K. Pratt , Todd W. Rockway , Clarence J. Maring , Douglas K. Hutchinson , Charles A. Flentge , Rolf Wagner , David A. Betebenner , Kathy Sarris , Kevin R. Woller , William A. Carroll
IPC分类号: A61K31/496 , A61K31/506 , A61K31/4545 , A61P31/14 , C07D403/14 , C07D401/14 , C07D405/14 , A61K31/4178 , A61K31/454
CPC分类号: C07D403/14 , C07D207/16
摘要: Compounds effective in inhibiting replication of Hepatitis C virus (“HCV”) are described. This invention also relates to processes of making such compounds, compositions comprising such compounds, and methods of using such compounds to treat HCV infection.
-
公开(公告)号:US20120082646A1
公开(公告)日:2012-04-05
申请号:US13260199
申请日:2010-03-25
申请人: David A. Betebenner , John K. Pratt , David A. DeGoey , Pamela L. Donner , Charles A. Flentge , Douglas K. Hutchinson , Warren M. Kati , Allan C. Krueger , Kenton L. Longenecker , Clarence J. Maring , John T. Randolph , Todd W. Rockway , Michael D. Tufano , Rolf Wagner , Dachun Liu
发明人: David A. Betebenner , John K. Pratt , David A. DeGoey , Pamela L. Donner , Charles A. Flentge , Douglas K. Hutchinson , Warren M. Kati , Allan C. Krueger , Kenton L. Longenecker , Clarence J. Maring , John T. Randolph , Todd W. Rockway , Michael D. Tufano , Rolf Wagner , Dachun Liu
IPC分类号: A61K31/513 , C07D409/08 , C07D213/64 , C07C311/08 , C07D233/72 , A61P31/14 , A61K31/18 , A61K31/4166 , A61K31/27 , C12N9/99 , A61K38/21 , A61K31/7056 , C07D239/54 , A61K31/4418
CPC分类号: C07D409/10 , A61K31/18 , A61K31/27 , A61K31/402 , A61K31/4166 , A61K31/421 , A61K31/425 , A61K31/4418 , A61K31/503 , A61K31/513 , A61K45/06 , C07C311/08 , C07D207/27 , C07D213/64 , C07D233/32 , C07D233/72 , C07D239/10 , C07D239/54 , C07D263/22 , C07D263/24 , C07D275/02 , C07D403/10 , C07D405/10 , Y02P20/55
摘要: This invention relates to: (a) compounds and salts thereof that, inter alia, inhibit HCV; (b) intermediates useful for the preparation of such compounds and salts; (c) compositions comprising such compounds and salts; (d) methods for preparing such intermediates, compounds, salts, and compositions; (e) methods of use of such compounds, salts, and compositions; and (f) kits comprising such compounds, salts, and compositions.
摘要翻译: 本发明涉及:(a)特别是抑制HCV的化合物及其盐; (b)可用于制备这些化合物和盐的中间体; (c)包含这些化合物和盐的组合物; (d)制备这种中间体,化合物,盐和组合物的方法; (e)使用这些化合物,盐和组合物的方法; 和(f)包含这些化合物,盐和组合物的试剂盒。
-
公开(公告)号:US20100249181A1
公开(公告)日:2010-09-30
申请号:US12813298
申请日:2010-06-10
申请人: David A. DeGoey , Charles A. Flentge , William J. Flosi , David J. Grampovnik , Dale J. Kempf , Larry L. Klein , Ming C. Yeung , John T. Randolph , Xiu C. Wang , Su Yu
发明人: David A. DeGoey , Charles A. Flentge , William J. Flosi , David J. Grampovnik , Dale J. Kempf , Larry L. Klein , Ming C. Yeung , John T. Randolph , Xiu C. Wang , Su Yu
IPC分类号: A61K31/4745 , C12N7/06 , A61K31/4439 , C07D403/02 , C07D471/02 , C07D498/02
CPC分类号: C07D213/56 , A61K31/426 , A61K31/4418 , A61K31/443 , A61K31/444 , A61K45/06 , C07C311/16 , C07D213/38 , C07D213/85 , C07D231/08 , C07D239/22 , C07D277/06 , C07D277/30 , C07D307/16 , C07D307/20 , C07D401/06 , C07D401/12 , C07D401/14 , C07D405/06 , C07D405/12 , C07D407/12 , C07D417/04 , C07D417/06 , C07D417/12 , C07D417/14 , C07D451/02 , C07D471/04 , C07D471/10 , C07D493/04 , C07F9/58 , C07F9/65515 , C07F9/65583 , C07K5/0207
摘要: A compound of the formula is disclosed as an HIV protease inhibitor. Methods and compositions for inhibiting an HIV infection are also disclosed.
摘要翻译: 公开了式的化合物作为HIV蛋白酶抑制剂。 还公开了用于抑制HIV感染的方法和组合物。
-
公开(公告)号:US20080161246A1
公开(公告)日:2008-07-03
申请号:US11846600
申请日:2007-08-29
申请人: Larry L. Klein , Hui-Ju Chen , Ming C. Yeung , Charles A. Flentge , John T. Randolph , Peggy P. Huang , Douglas K. Hutchinson , Dale J. Kempf
发明人: Larry L. Klein , Hui-Ju Chen , Ming C. Yeung , Charles A. Flentge , John T. Randolph , Peggy P. Huang , Douglas K. Hutchinson , Dale J. Kempf
CPC分类号: A61K31/5377 , A61K31/4164 , A61K31/4178 , A61K31/4439 , A61K31/4525 , A61K31/496 , A61K31/506 , A61K45/06 , C07D213/79 , C07D277/24 , C07D277/30 , C07D277/593 , C07D417/12
摘要: The present invention features compounds of formula I or pharmaceutically acceptable salts, solvates or prodrugs thereof, and methods of using the same to inhibit the metabolizing activities of CYP enzymes. The present invention also features methods of using these compounds, salts, solvates or prodrugs to improve the pharmacokinetics of drugs that are metabolized by CYP enzymes.
摘要翻译: 本发明的特征在于式I化合物或其药学上可接受的盐,溶剂合物或前药,以及使用该化合物抑制CYP酶代谢活性的方法。 本发明还涉及使用这些化合物,盐,溶剂合物或前药来改善由CYP酶代谢的药物的药代动力学的方法。
-
-
-
-
-
-
-
-
-